The prognostic and predictive roles of plasma C‐reactive protein and PD‐L1 in non‐small cell lung cancer

BACKGROUND: Anti‐PD‐(L)1 agents have revolutionized the treatment paradigms of non‐small cell lung cancer (NSCLC), while predictive biomarkers are limited. It has been previously shown that systemic inflammation, indicated by elevated C‐reactive protein (CRP) level, is associated with a poor prognos...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuusisalo, Saara, Tikkanen, Antti, Lappi‐Blanco, Elisa, Väisänen, Timo, Knuuttila, Aija, Tiainen, Satu, Ahvonen, Jarkko, Iivanainen, Sanna, Koivunen, Jussi P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469721/
https://www.ncbi.nlm.nih.gov/pubmed/37329173
http://dx.doi.org/10.1002/cam4.6262

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469721/
https://www.ncbi.nlm.nih.gov/pubmed/37329173
http://dx.doi.org/10.1002/cam4.6262

Ejemplares similares